GENCOR INDUSTRIES INC (GENC): Nasdaq/NYSE listing notice — Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing

GENCOR INDUSTRIES INC

Received delinquency notice from NYSE American on May 19, 2026 for failure to timely file Q2 2026 10-Q (due May 18, 2026).
Company has six months from May 18, 2026 to file the 10-Q and regain compliance; possible six-month extension at NYSE's discretion.
NYSE may commence suspension/delisting proceedings at any time if circumstances warrant.
No immediate effect on listing or trading of common stock (GENC); company expects to file within the six-month period but no assurance.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GENCOR INDUSTRIES INC received a nyse_american deficiency notice notice regarding late filing (rules 1007).

Exchange: nyse american
Notice: deficiency notice
Deficiency: late filing
Rules: 1007

Exact text from the filing

May 19, 2026, Gencor Industries, Inc. (the “Company”) received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company was not in compliance with the NYSE American LLC (“NYSE American”) continued listing standards as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”) with the Securities and Exchange Commission (“SEC”) prior to May 18, 2026, the end of the extension period provided by Form 12b-25, and as a result was subject to the procedures set forth in Section 1007 of the NY

View on SEC.gov

Browse all listing & compliance notices →

GENCOR INDUSTRIES INC filing history →

Source: SEC EDGAR

accession 0001193125-26-251421

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.